Dr. Zinner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Mount Auburn St
Cambridge, MA 02138Phone+1 617-499-5026Fax+1 617-499-5453
Education & Training
- Boston University Medical CenterResidency, Internal Medicine, 1970 - 1971
- University of ChicagoResidency, Internal Medicine, 1965 - 1967
- Perelman School of Medicine at the University of PennsylvaniaClass of 1965
Certifications & Licensure
- CA State Medical License 1970 - 2025
- MA State Medical License 1967 - 2025
- RI State Medical License 1972 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1983
Publications & Presentations
PubMed
- 99 citationsVancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.A. Cometta, Winfried V. Kern, R. De Bock, Marianne Paesmans, M. Vandenbergh
Clinical Infectious Diseases. 2003-08-01 - 362 citationsThree antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.Stephen C. Schimpff, H. Gaya, Jean Klastersky, Tattersall Mh, Stephen H. Zinner
The Journal of Infectious Diseases. 1978-01-01 - 176 citationsPiperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimic...A. Cometta, Stephen H. Zinner, R. De Bock, Thierry Calandra, H Gaya
Antimicrobial Agents and Chemotherapy. 1995-02-01
Journal Articles
- Predicting Antibiotic Combination Effects on the Selection of Resistant Staphylococcus Aureus: In Vitro Model Studies with Linezolid and GentamicinStephen Zinner, MD, International Journal of Antimicrobial Agents
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: